Persistent Asset Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
Persistent Asset Partners's ZNTL Position: Q3 2026 in Review
Persistent Asset Partners opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 28,801 shares worth $79.8K. The stake represents 0.02% of the portfolio and ranks #340 among its holdings.
128 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Persistent Asset Partners held 28,801 shares of Zentalis Pharmaceuticals worth $79.8K as of Q3 2026.
- Zentalis Pharmaceuticals was a new Persistent Asset Partners position in Q3 2026.
- Zentalis Pharmaceuticals made up 0.02% of Persistent Asset Partners's portfolio in Q3 2026, its #340 holding.
- 128 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.